or Try an Advanced Search...

    Technical Analysis for OGN - Organon & Co.

    Grade Last Price % Change Price Change
    F 14.80 0.48% 0.07
    OGN closed up 0.96 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical OGN trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.48%
    Inside Day Range Contraction 0.48%
    Oversold Stochastic Weakness 0.48%
    Gapped Down Weakness 1.44%
    Oversold Stochastic Weakness 1.44%
    Oversold Stochastic Weakness -1.99%
    Oversold Stochastic Weakness -1.53%
    Oversold Stochastic Weakness -3.33%
    Slingshot Bearish Bearish Swing Setup -5.19%
    Oversold Stochastic Weakness -5.19%
    Older End-of-Day Signals for OGN ...

       Recent Intraday Alerts

    Alert Time
    Up 1% 8 minutes ago
    Rose Above Previous Day's High 32 minutes ago
    Possible NR7 about 20 hours ago
    Possible Inside Day about 20 hours ago
    Up 1% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    OGN Chart by TradingView
    Basic chart:

    Profile

    Organon & Co., a science-based pharmaceutical company, develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon & Co. operates independently of Merck & Co., Inc. as of June 2, 2021.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - General
    Keywords: Life Sciences Pharmaceutical Health Care Health Solutions Biosimilar

    Is OGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Organon: 7% Yield, 4x P/E, Big Upside Potential
    Nov 13 Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)
    Nov 8 Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem
    Nov 5 Earnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
    Nov 5 Organon updates outlook as FDA delays VTAMA label expansion
    Nov 5 Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
    Nov 3 Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
    Nov 1 Organon Third Quarter 2024 Earnings: EPS: US$1.39 (vs US$0.23 in 3Q 2023)
    Oct 31 Organon & Co. 2024 Q3 - Results - Earnings Call Presentation
    Oct 31 Organon & Co. (OGN) Q3 2024 Earnings Call Transcript
    See more OGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.698
    52 Week Low 10.1994
    Average Volume 2,516,231
    200-Day Moving Average 18.68
    50-Day Moving Average 17.55
    20-Day Moving Average 16.20
    10-Day Moving Average 15.34
    Average True Range 0.53
    RSI (14) 27.54
    ADX 38.57
    +DI 11.79
    -DI 35.68
    Chandelier Exit (Long, 3 ATRs) 17.12
    Chandelier Exit (Short, 3 ATRs) 15.98
    Upper Bollinger Bands 18.35
    Lower Bollinger Band 14.05
    Percent B (%b) 0.16
    BandWidth 26.56
    MACD Line -0.81
    MACD Signal Line -0.72
    MACD Histogram -0.0924
    Fundamentals Value
    Market Cap 3.77 Billion
    Num Shares 256 Million
    EPS 2.28
    Price-to-Earnings (P/E) Ratio 6.46
    Price-to-Sales 0.68
    Price-to-Book 1.84
    Dividend 1.12
    Dividend Yield 7.60%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 15.23
    Resistance 3 (R3) 15.19 14.98 15.14
    Resistance 2 (R2) 14.98 14.86 15.00 15.11
    Resistance 1 (R1) 14.86 14.78 14.92 14.90 15.09
    Pivot Point 14.65 14.65 14.69 14.67 14.65
    Support 1 (S1) 14.53 14.53 14.59 14.57 14.37
    Support 2 (S2) 14.32 14.45 14.34 14.35
    Support 3 (S3) 14.20 14.32 14.32
    Support 4 (S4) 14.24